SBUX
41
-3
WFC
63
3
MOS
19
-4
NWSA
47
-2
AMP
66
-4
HRL
30
-5
INTC
43
6
ZTS
56
-2
HON
47
-12
EXPD
53
-3
IP
39
-6
KEY
51
-3
BAX
30
-3
HOG
50
6
HSIC
50
-3
TRIP
66
5
EMR
57
-3
XRX
52
-3
PLD
51
-5
ITW
62
-2
SBUX
41
-3
WFC
63
3
MOS
19
-4
NWSA
47
-2
AMP
66
-4
HRL
30
-5
INTC
43
6
ZTS
56
-2
HON
47
-12
EXPD
53
-3
IP
39
-6
KEY
51
-3
BAX
30
-3
HOG
50
6
HSIC
50
-3
TRIP
66
5
EMR
57
-3
XRX
52
-3
PLD
51
-5
ITW
62
-2
Financhill
Back

Integra Lifesciences Holdings Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
22

IART
Integra Lifesciences Holdings

Last Price:
17.41
Seasonality Move:
-0.77%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
22
Integra Lifesciences Holdings (IART) is a Sell

Is Integra Lifesciences Holdings a Buy, Sell or Hold?

  • The current Integra Lifesciences Holdings [IART] share price is $17.41. The Score for IART is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • IART is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

IART Stock Price Chart

What is Integra Lifesciences Holdings's stock price today?

  • The Integra Lifesciences Holdings share price today is $17.41
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IART is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

IART Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.49 Sell
Relative Strength Index (14 RSI): 24.97 Sell
Chaikin Money Flow: 872748 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.65 - 20.79) Sell
Bollinger Bands (100): (21.09 - 30.45) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

IART Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.45 Sell
20-day SMA: 18.76 Sell
50-day SMA: 22.88 Sell
200-day SMA: 32.28 Sell
8-day EMA: 17.62 Sell
20-day EMA: 18.77 Sell
50-day EMA: 21.82 Sell
200-day EMA: 30.27 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Integra Lifesciences Holdings Earnings Growth & IART Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.39 per share, an increase next quarter of $0.21 per share, a decrease this year of $0.66 per share, and an increase next year of $0.06 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Integra Lifesciences Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):